Literature DB >> 31858213

Association of milk consumption frequency on muscle mass and strength: an analysis of three representative Korean population studies.

Yu-Jin Kwon1,2, Ji-Won Lee3, Jun-Hyuk Lee4,5, Hye Sun Lee6, Hyungmi Kim7.   

Abstract

PURPOSE: Sarcopenia is an involuntary loss of muscle mass, strength, and physical performance associated with aging. Sarcopenia contributes to adverse health outcomes. Milk contains essential amino acids important for maintaining muscle. We investigated the relationships among milk consumption frequency (MCF), muscle mass, and strength in Korean adults.
METHODS: We analyzed the data from 16,173 adults in the 2008-2011 Korean National Health and Nutrition Examination Survey (KNHANES), 13,537 adults in the 2014-2016 KNHANES, and 8254 adults in the Korean Genome and Epidemiology Study (KoGES). MCF was divided into two groups: (1) MCF less than once per day (MCF < 1 group) and (2) MCF greater than or equal to once per day (MCF ≥ 1 group). Low skeletal muscle mass index (LSMI) was defined using the Foundation for the National Institutes of Health sarcopenia project criteria for low muscle mass. Muscle strength was measured using the hand-grip strength test.
RESULTS: The odds ratio (95% confidence interval) for LSMI in the MCF < 1 group was 1.250 (1.013-1.543) after adjusting for confounding factors, compared with the MCF ≥ 1 group (2008-2011 KNHANES). The adjusted mean for hand-grip strength was higher in the MCF ≥ 1 group (2014-2016 KNHANES). After a mean follow-up of 9 years, fat-free mass/body mass index was higher in the MCF ≥ 1 group than the MCF < 1 group (KoGES).
CONCLUSION: We found that MCF ≥ 1 was significantly associated with higher skeletal muscle index and muscle strength than lower MCF. Milk consumption could help prevent sarcopenia in adults.

Entities:  

Keywords:  Milk consumption frequency; Muscle mass; Muscle strength; Sarcopenia

Mesh:

Year:  2019        PMID: 31858213     DOI: 10.1007/s00394-019-02164-5

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  48 in total

Review 1.  Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group.

Authors:  Jürgen Bauer; Gianni Biolo; Tommy Cederholm; Matteo Cesari; Alfonso J Cruz-Jentoft; John E Morley; Stuart Phillips; Cornel Sieber; Peter Stehle; Daniel Teta; Renuka Visvanathan; Elena Volpi; Yves Boirie
Journal:  J Am Med Dir Assoc       Date:  2013-07-16       Impact factor: 4.669

2.  Financial impact of sarcopenia on hospitalization costs.

Authors:  A S Sousa; R S Guerra; I Fonseca; F Pichel; S Ferreira; T F Amaral
Journal:  Eur J Clin Nutr       Date:  2016-05-11       Impact factor: 4.016

Review 3.  Nutritional recommendations for the management of sarcopenia.

Authors:  John E Morley; Josep M Argiles; William J Evans; Shalender Bhasin; David Cella; Nicolaas E P Deutz; Wolfram Doehner; Ken C H Fearon; Luigi Ferrucci; Marc K Hellerstein; Kamyar Kalantar-Zadeh; Herbert Lochs; Neil MacDonald; Kathleen Mulligan; Maurizio Muscaritoli; Piotr Ponikowski; Mary Ellen Posthauer; Filippo Rossi Fanelli; Morrie Schambelan; Annemie M W J Schols; Michael W Schuster; Stefan D Anker
Journal:  J Am Med Dir Assoc       Date:  2010-07       Impact factor: 4.669

4.  The role of acetyl-CoA in the reaction pathway of pig-liver pyruvate carboxylase.

Authors:  G B Warren; K F Tipton
Journal:  Eur J Biochem       Date:  1974-09-16

5.  The epidemiology of sarcopenia.

Authors:  Ian Janssen
Journal:  Clin Geriatr Med       Date:  2011-05-14       Impact factor: 3.076

6.  Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.

Authors:  Nicolaas E P Deutz; Jürgen M Bauer; Rocco Barazzoni; Gianni Biolo; Yves Boirie; Anja Bosy-Westphal; Tommy Cederholm; Alfonso Cruz-Jentoft; Zeljko Krznariç; K Sreekumaran Nair; Pierre Singer; Daniel Teta; Kevin Tipton; Philip C Calder
Journal:  Clin Nutr       Date:  2014-04-24       Impact factor: 7.324

7.  Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

Authors:  Tae Nyun Kim; Man Sik Park; Sae Jeong Yang; Hye Jin Yoo; Hyun Joo Kang; Wook Song; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

8.  Relation of Muscle Mass and Fat Mass to Cardiovascular Disease Mortality.

Authors:  Preethi Srikanthan; Tamara B Horwich; Chi Hong Tseng
Journal:  Am J Cardiol       Date:  2016-02-02       Impact factor: 2.778

9.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

10.  The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.

Authors:  Stephanie A Studenski; Katherine W Peters; Dawn E Alley; Peggy M Cawthon; Robert R McLean; Tamara B Harris; Luigi Ferrucci; Jack M Guralnik; Maren S Fragala; Anne M Kenny; Douglas P Kiel; Stephen B Kritchevsky; Michelle D Shardell; Thuy-Tien L Dam; Maria T Vassileva
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more
  2 in total

1.  Effect of Dairy Protein Intake on Muscle Mass among Korean Adults: A Prospective Cohort Study.

Authors:  Eunjin So; Hyojee Joung
Journal:  Nutrients       Date:  2020-08-21       Impact factor: 5.717

2.  Association of protein consumption and energy intake on sarcopenia in tuberculosis survivors.

Authors:  Moon-Kyung Shin; Ji Yeon Choi; Song Yee Kim; Eun Young Kim; Sang Hoon Lee; Kyung Soo Chung; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Young Ae Kang
Journal:  Ther Adv Chronic Dis       Date:  2021-11-18       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.